Leslie D. Funtleyder
CIK 1775394 · Chief Financial Officer · last filed 2026-02-03
Leslie D. Funtleyder is a Chief Financial Officer who has filed 32 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for APLT, was dated Feb 3, 2026. Across all open-market trades the lifetime net is −$5.0M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
32
-$4.95M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Applied Therapeutics, Inc. (APLT) Delisted | Chief Financial Officer | 0 | $0.10 | $0 | -$4.95M | 26 | 2026-02-03 |
| RVPH | Director | — | $0.71 | — | $0 | 1 | 2025-12-19 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) Delisted | Director | — | $0.00 | — | $0 | 5 | 2024-12-12 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-03 | Applied Therapeutics, Inc. (APLT) Delisted | Mixed | −1,340,459 | $0 | EDGAR |
| 2026-01-02 | Applied Therapeutics, Inc. (APLT) Delisted | Grant (A) | +150,000 | $0 | EDGAR |
| 2025-12-19 | RVPH | Grant (A) | — | $0 | EDGAR |
| 2025-10-01 | Applied Therapeutics, Inc. (APLT) Delisted | Grant (A) | +150,000 | $0 | EDGAR |
| 2025-07-03 | Applied Therapeutics, Inc. (APLT) Delisted | Grant (A) | +300,000 | $0 | EDGAR |
| 2025-03-26 | Applied Therapeutics, Inc. (APLT) Delisted | Grant (A) | +350,000 | $0 | EDGAR |
| 2025-03-06 | Applied Therapeutics, Inc. (APLT) Delisted | Sell (S) | −14,502 | -$6.4K | EDGAR |
| 2025-02-07 | Applied Therapeutics, Inc. (APLT) Delisted | Sell (S) | −22,950 | -$14.0K | EDGAR |
| 2024-12-20 | Applied Therapeutics, Inc. (APLT) Delisted | Grant (A) | +150,000 | $0 | EDGAR |
| 2024-12-12 | REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW) Delisted | Grant (A) | — | $0 | EDGAR |